Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Odile Launay

Showing results (251-260 of 305) with videos related to

Pageof 31
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 25, 2022
T Cell Immunogenicity, Gene Expression Profile, and Safety of Four Heterologous Prime-Boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: Results of the Randomized Multi-Arm Phase I/II ANRS VRI01 TrialLaura Richert, Jean-Daniel Lelièvre, Christine Lacabaratz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2013
Longitudinal and integrative biomodeling of effector and memory immune compartments after inactivated influenza vaccinationOlivia Bonduelle, Nora Yahia, Sophie Siberil, et al.
The Journal of Antimicrobial Chemotherapy|January 23, 2023
Striking differences in weight gain after cART initiation depending on early or advanced presentation: results from the ANRS CO4 FHDH cohortSophie Grabar, Valérie Potard, Lionel Piroth, et al.
Influenza and Other Respiratory Viruses|April 8, 2014
Influenza symptoms and their impact on elderly adults: randomised trial of AS03-adjuvanted or non-adjuvanted inactivated trivalent seasonal influenza vaccinesGerrit A van Essen, Jiri Beran, Jeanne-Marie Devaster, et al.
Influenza and Other Respiratory Viruses|February 6, 2020
Vaccine effectiveness against influenza A(H3N2) and B among laboratory-confirmed, hospitalised older adults, Europe, 2017-18: A season of B lineage mismatched to the trivalent vaccineAngela M C Rose, Esther Kissling, Alin Gherasim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 20, 2026
Recombinant vs Standard Influenza Vaccine in Adults With Severe Obesity: A Randomized Clinical TrialPaul Loubet, Sébastien Czernichow, Caroline Giboin, et al.
The Journal of Infectious Diseases|February 1, 2014
Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illnessAnn R Falsey, Janet E McElhaney, Jiri Beran, et al.
Journal of Gynecology Obstetrics and Human Reproduction|December 14, 2020
SARS-COV-2 IgG antibody response in pregnant women at deliveryVassilis Tsatsaris, Alice-Andrée Mariaggi, Odile Launay, et al.
Msphere|April 16, 2025
Protein-specific immune response elicited by the <i>Shigella sonnei</i> 1790GAHB GMMA-based candidate vaccine in adults with varying exposure to <i>Shigella</i>Arlo Z Randall, Valentino Conti, Usman Nakakana, et al.
Ebiomedicine|January 19, 2022
Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I studyOdile Launay, Cécile Artaud, Marie Lachâtre, et al.
Pageof 31

Showing results (251-260 of 305) with videos related to

Sort By:
Pageof 31
Journal of Immunology (Baltimore, Md. : 1950)|May 25, 2022
T Cell Immunogenicity, Gene Expression Profile, and Safety of Four Heterologous Prime-Boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: Results of the Randomized Multi-Arm Phase I/II ANRS VRI01 TrialLaura Richert, Jean-Daniel Lelièvre, Christine Lacabaratz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2013
Longitudinal and integrative biomodeling of effector and memory immune compartments after inactivated influenza vaccinationOlivia Bonduelle, Nora Yahia, Sophie Siberil, et al.
The Journal of Antimicrobial Chemotherapy|January 23, 2023
Striking differences in weight gain after cART initiation depending on early or advanced presentation: results from the ANRS CO4 FHDH cohortSophie Grabar, Valérie Potard, Lionel Piroth, et al.
Influenza and Other Respiratory Viruses|April 8, 2014
Influenza symptoms and their impact on elderly adults: randomised trial of AS03-adjuvanted or non-adjuvanted inactivated trivalent seasonal influenza vaccinesGerrit A van Essen, Jiri Beran, Jeanne-Marie Devaster, et al.
Influenza and Other Respiratory Viruses|February 6, 2020
Vaccine effectiveness against influenza A(H3N2) and B among laboratory-confirmed, hospitalised older adults, Europe, 2017-18: A season of B lineage mismatched to the trivalent vaccineAngela M C Rose, Esther Kissling, Alin Gherasim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 20, 2026
Recombinant vs Standard Influenza Vaccine in Adults With Severe Obesity: A Randomized Clinical TrialPaul Loubet, Sébastien Czernichow, Caroline Giboin, et al.
The Journal of Infectious Diseases|February 1, 2014
Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illnessAnn R Falsey, Janet E McElhaney, Jiri Beran, et al.
Journal of Gynecology Obstetrics and Human Reproduction|December 14, 2020
SARS-COV-2 IgG antibody response in pregnant women at deliveryVassilis Tsatsaris, Alice-Andrée Mariaggi, Odile Launay, et al.
Msphere|April 16, 2025
Protein-specific immune response elicited by the <i>Shigella sonnei</i> 1790GAHB GMMA-based candidate vaccine in adults with varying exposure to <i>Shigella</i>Arlo Z Randall, Valentino Conti, Usman Nakakana, et al.
Ebiomedicine|January 19, 2022
Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I studyOdile Launay, Cécile Artaud, Marie Lachâtre, et al.
Pageof 31